Forum Markets, Inc. (FRMM)
5.54
+0.26
(+4.92%)
USD |
NASDAQ |
Sep 02, 16:00
5.54
0.00 (0.00%)
After-Hours: 18:50
Forum Markets Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2025 | 1.511M |
| March 31, 2025 | 1.810M |
| December 31, 2024 | 1.969M |
| September 30, 2024 | 1.524M |
| June 30, 2024 | 2.226M |
| March 31, 2024 | 2.525M |
| December 31, 2023 | 2.784M |
| September 30, 2023 | 3.407M |
| June 30, 2023 | 2.938M |
| Date | Value |
|---|---|
| March 31, 2023 | 2.521M |
| December 31, 2022 | 2.433M |
| September 30, 2022 | 3.818M |
| June 30, 2022 | 3.762M |
| March 31, 2022 | 4.224M |
| December 31, 2021 | 3.855M |
| September 30, 2021 | 2.352M |
| June 30, 2021 | 2.173M |
| March 31, 2021 | 1.679M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abeona Therapeutics, Inc. | 23.37M |
| Corcept Therapeutics, Inc. | 253.86M |
| ACADIA Pharmaceuticals, Inc. | 331.01M |
| Alnylam Pharmaceuticals, Inc. | 1.509B |
| Anika Therapeutics, Inc. | 27.45M |